Vendor, Nashville, TN
Revance Therapeutics, Inc.
UEI HY78DQBTLLG3, CAGE 9QP59
2 awards and $0 obligated between February 14, 2024 and December 11, 2025, 100% under full and open competition, against 999.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Revance Therapeutics, Inc. 65IB 36F79724D0115 Effective 5-15-2024 through 5-14-2024
Department of Veterans Affairs, Nac Federal Supply Schedule
Award noticeNAICS 32541236F79724D0115Awarded to Revance Therapeutics, Inc. for $225,000
Posted Apr 22, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36F79724D0115April 22, 2024, Full and Open Competition, 999 offersSolicitation | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract AwardNAICS 325412, PSC 6505 | $0 |
| 36F79724D014EFebruary 14, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Interim Agreement Under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related ProductsNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 7 across 2 awards